Nexalin Technology, Inc. , a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China.
Nexalin Technology stock last closed at $0.38, up 7.04% from the previous day, and has decreased 78.77% in one year. It has underperformed other stocks in the Medical Devices industry by 0.18 percentage points. Nexalin Technology stock is currently +15.15% from its 52-week low of $0.33, and -81% from its 52-week high of $2.00.
As of May 1, 2026, there are 20.58M NXL shares outstanding. The market cap of NXL is $7.82M. In the past 24 hours, 142,000 NXL shares were traded.
You will need a brokerage account to access the NASDAQ market and buy NXL stock.
In our opinion, eToro is the best stock brokerage. Here's why:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the best brokerage, the next step is to fill out some personal details so you are able to buy NXL stock today.
Now that you have opened your account on one of the best stock trading apps, your next step is to transfer the money for your investment:
Check out the walkthrough below to see the process of depositing money into your new brokerage account.
After you have identified the best place to buy Nexalin Technology stock, it's crucial to analyze their stock prior to buying, so you can understand the risk as well as the upside.
WallStreetZen was created to help everyday investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on NXL's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge NXL's true value.
Using relative valuations ratios:
You can access additional valuation analysis on NXL's stock here.
You can dig deeper into what analysts are forecasting on the Nexalin Technology stock forecast page.
Last year, NXL revenue was $301.65k. In the past 5 year, NXL's revenue has gone up by 4.43% per year. This was slower than the Medical Devices industry average of 10.81%.
You can analyze NXL's earnings and revenue performance here.
In the last year, executives and large shareholders at NXL have not bought or sold any shares.
Research more about who owns NXL shares here.
No, Nexalin Technology doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary order types:
Press the Open Trade button and your broker will place the order.
If you require additional assistance investing in stocks on eToro, click the helpful video below:
Now that you own some NXL stock, you'll want to stay up-to-date on your shares.
Create a watchlist to track the latest developments regarding your NXL stock.
To summarize, here are the 6 steps to buy Nexalin Technology stock:
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Nexalin Technology, hit the button below to create your watchlist.